Vicarious Surgical RBOT
OTC RBOT
$0.04 -0.01 (-17.05%)
At close: Aug 19, 2026 · 3:39 PM UTC

Vicarious Surgical (RBOT) Liabilities and Shareholders Equity (2020 - 2025)

Vicarious Surgical (RBOT) posted quarterly Liabilities and Shareholders Equity of $19.6 million for Q4 2025, down 71.08% year-over-year from $67.7 million in Q4 2024, and down 33.28% quarter-over-quarter from $29.3 million in Q3 2025.

Vicarious Surgical (RBOT) Liabilities and Shareholders Equity (2020 - 2025) Analysis & Trends

Vicarious Surgical (RBOT) has reported Liabilities and Shareholders Equity for 6 consecutive years, with $19.6 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Liabilities and Shareholders Equity fell 71.08% year-over-year to $19.6 million; the TTM figure through Dec 2025 stood at $144.9 million (down 58.25% YoY), while the FY2025 annual figure was $19.6 million, down 71.08% from the prior year.
  • Liabilities and Shareholders Equity eased to $19.6 million in Q4 2025 per RBOT's latest filing, from $29.3 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $346.4 million in Q1 2021 and bottomed at $19.6 million in Q4 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $133.6 million across 5 years, with a median of $120.5 million in 2023.
  • Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity jumped 89224.63% — and 2025, when it sank 71.08%.
  • Vicarious Surgical's Liabilities and Shareholders Equity stood at $181.7 million in 2021, then retreated by 22.78% to $140.3 million in 2022, then declined by 14.56% to $119.9 million in 2023, then plunged by 43.5% to $67.7 million in 2024, then slumped by 71.08% to $19.6 million in 2025.
  • Business Quant data shows RBOT's Liabilities and Shareholders Equity at $19.6 million in Q4 2025, $29.3 million in Q3 2025, and $40.9 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn 109.22 Bn
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn 31.04 Bn
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn 10.74 Bn
10 Vicarious Surgical 196,495.36 -14.84 Mn - 19.58 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 19.58 Mn
Sep 30, 2025 29.35 Mn
Jun 30, 2025 40.89 Mn
Mar 31, 2025 55.05 Mn
Dec 31, 2024 67.72 Mn
Sep 30, 2024 80.62 Mn
Jun 30, 2024 93.35 Mn
Mar 31, 2024 105.29 Mn
Dec 31, 2023 119.86 Mn
Sep 30, 2023 132.05 Mn
Jun 30, 2023 104.53 Mn
Mar 31, 2023 121.09 Mn
Dec 31, 2022 140.29 Mn
Sep 30, 2022 150.68 Mn
Jun 30, 2022 164.05 Mn
Mar 31, 2022 179.97 Mn
Dec 31, 2021 181.68 Mn
Sep 30, 2021 193.36 Mn
Jun 30, 2021 345.54 Mn
Mar 31, 2021 346.35 Mn